TACSTD2 and cancer: While downregulation of TACSTD2 is part of a gene expression profile signature that predicts increased risk of cancer progression, LGALS7 is involved in promoting cellular apoptosis and could therefore lead to increased tumor cell survival (Biron‐Pain et al, 2013; Gerami et al, 2015).